#YourHealingBeginsHere

10|2025

Clinical Proof – A Scientifically Validated Approach   

Proven Effectiveness: NeuroStar® Advanced Therapy has delivered over 7.1 million treatments, benefiting over 195,000 patients across more than 1,100 practices in the U.S. It is recognized as the market leader in clinical practice for depression treatment. Long-Term Efficacy: NeuroStar has demonstrated long-term effectiveness with established durability for up to 12 months post-treatment. This indicates sustained… Read more »

#YourHealingBeginsHere

10|2025

NeuroStar TMS for Teens With Major Depressive Disorder: Exploring the Latest Findings

Main Findings from the Data Presented at the 2024 AACAP Annual Conference on NeuroStar® TMS for Adolescents: 1. High Remission and Response Rates:    – Nearly 60% of adolescents aged 12-19 with Major Depressive Disorder (MDD) achieved remission after treatment with NeuroStar Advanced TMS.    – The remission rate for young adults aged 20-21 was… Read more »